Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.
Human Papillomavirus (HPV), a non-enveloped, double-stranded DNA virus, is responsible for 5% of human cancers. The HPV capsid consists of major and minor structural proteins, L1 and L2. L1 proteins form an icosahedral shell with building blocks of the pentameric capsomere, and one L2 molecule exten...
Main Authors: | Daning Wang, Zhihai Li, Jieqiong Xiao, Junqi Wang, Li Zhang, Yajing Liu, Fei Fan, Lu Xin, Minxi Wei, Zhibo Kong, Hai Yu, Ying Gu, Jun Zhang, Shaowei Li, Ningshao Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4408011?pdf=render |
Similar Items
-
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
by: Lingyan Cui, et al.
Published: (2024-06-01) -
A Comprehensive Evaluation of the HPV Neutralizing Antibodies in Guangzhou, China: A Comparative Study on Various HPV Vaccines
by: Renyun Zha, et al.
Published: (2024-11-01) -
A single residue switch mediates the broad neutralization of Rotaviruses
by: Yang Huang, et al.
Published: (2025-01-01) -
Position Statement about Gender-Neutral HPV Vaccination in Korea
by: Kyung-Jin Min, et al.
Published: (2024-09-01) -
Benefits of Gender-Neutral Vaccination Strategy for the Prevention of HPV-Associated Diseases and the Eradication of HPV Infection in General. Current State of HPV Vaccination in the World
by: Tatiana E. Privalova, et al.
Published: (2021-07-01)